A Major Susceptibility Locus on Chromosome 22q12 Plays a Critical Role in the Control of Kala-Azar

American Journal of Human Genetics

Volumn 73, Issue 5, 2003, Pages 1052-1060

  Bucheton, Bruno ^a   Abel, Laurent ^b   El Safi, Sayda ^c   Kheir, Musa M ^c   Pavek, Sylvana ^d   Lemainque, Arnaud ^d   Dessein, Alain J ^a,e  

^a INSERM   (France)

^b IMAGINE INSTITUTE   (France)

^c UNIVERSITY OF KHARTOUM   (Sudan)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^e TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA MARKER;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 22Q; CHROMOSOME BAND; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENE LOCUS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INFECTION CONTROL; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA INFANTUM; NASO HEXACANTHUS;

EID: 0242574584     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/379084     Document Type: Article

References (44)

1. Abel L, Alcais A, Mallet A (1998) Comparison of four sibpair linkage methods for analyzing sibships with more than two affecteds: interest of the binomial maximum likelihood approach. Genet Epidemiol 15:371-390
2. Abel L, Muller-Myhsok B (1998) Robustness and power of the maximum-likelihood-binomial and maximum-likelihood-score methods, in multipoint linkage analysis of affected-sibship data. Am J Hum Genet 63:638-647
3. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD Jr (1986a) New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 154:1003-1011
4. Badaro R, Jones TC, Lorenco R, Cerf BJ, Sampaio D, Carvalho EM, Rocha H, Teixeira R, Johnson WD Jr (1986b) A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis 154:639-649
5. Barbier D, Demenais F, Lefait JF, David B, Blanc M, Hors J, Feingold N (1987) Susceptibility to human cutaneous leishmaniasis and HLA, Gm, Km markers. Tissue Antigens 30: 63-67
6. Barral-Netto M, Barrai A, Santos SB, Carvalho EM, Badaro R, Rocha H, Reed SG, Johnson WD Jr (1991) Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol 147:281-284
7. Beebe AM, Mauze S, Schork NJ, Coffman RL (1997) Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551-557
8. Blackwell JM (1996) Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112:S67-S74
9. Blackwell JM (1983) Regulation of Leishmania populations within the host. V. Resistance L. donovani in wild mice. J Trop Med Hyg 86:17-22
10. Blackwell J, Freeman J, Bradley D (1980) Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice. Nature 283:72-74
11. Blackwell JM, Searle S, Mohamed H, White JK (2003) Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/ Nramp1/Slc11a1 gene story. Immunol Lett 85:197-203
12. Bradley DJ, Taylor BA, Blackwell J, Evans EP, Freeman J (1979) Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol 37: 7-14.
13. Bucheton B, Abel L, Kheir MM, Mirgani A, El-Safi SH, Chevillard C, Dessein A (2003) Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun 4:104-109
14. Bucheton B, El-Safi SH, Hammad A, Kheir MM, Eudes N, Mirgani A, Dessein AJ, Mary C. Anti-Leishmania antibodies in an outbreak of visceral leishmaniasis in eastern Sudan: high antibody reponses occur in resistant subjects and are not predictive of disease. Trans R Soc Trop Med Hyg, in press
15. Bucheton B, Kheir MM, El-Safi SH, Hammad A, Mergani A, Mary C, Abel L, Dessein A (2002) The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 4: 1449-1457
16. Cabello PH, Lima AM, Azevedo ES, Krieger H (1995) Familial aggregation of Leishmania chagasi infection in northeastern Brazil. Am J Trop Med Hyg 52:364-365
17. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182:1259-1264
18. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD Jr (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76:2066-2069
19. Carvalho EM, Teixeira RS, Johnson WD Jr (1981) Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun 33:498-500
20. Demant P, Lipoldova M, Svobodova M (1996) Resistance to Leishmania major in mice. Science 274:1392-1393
21. Desjeux P (1996) Leishmaniasis: public health aspects and control. Clin Dermatol 14:417-423
22. Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95:239-243
23. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154
24. El-Safi S, Bucheton B, Kheir MM, Musa HA, Hammad A, Dessein A (2002) Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). Microbes Infect 4:1439-1447
25. Göring HH, Terwilliger JD, Blangero J (2001) Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 69:1357-1369
26. Ibrahim ME, Lambson B, Yousif AO, Deifalla NS, Alnaiem DA, Ismail A, Yousif H, Ghalib HW, Khalil EA, Kadaro A, Barker DC, El Hassan AM (1999) Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 61:941-944
27. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
28. Lambert M, Dereure J, El-Safi SH, Bucheton B, Dessein A, Boni M, Feugier E, Dedet JP (2002) The sandfly fauna in the visceral-leishmaniasis focus of Gedaref, in the Atbara-River area of eastern Sudan. Ann Trop Med Parasitol 96: 631-636
29. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
30. Lara ML, Layrisse Z, Scorza JV, Garcia E, Stoikow Z, Granados J, Bias W (1991) Immunogenetics of human American cutaneous leishmaniasis: study of HLA haplotypes in 24 families from Venezuela. Hum Immunol 30:129-135
31. Liu J, Fujiwara TM, Buu NT, Sanchez FO, Cellier M, Paradis AJ, Frappier D, et al (1995) Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 56:845-853
32. Majumder S, Kierszenbaum F (1996) Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function: inhibition of transcription and expression of IL-2 receptor γ (p64IL-2R) and β (p70IL-2R) chain molecules in activated normal human lymphocytes. J Immunol 156: 3866-3874
33. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, Feingold J, Weissenbach J, Dessein AJ (1996) Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 14:181-184
34. Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, Verner A, Hudson TJ, Abel L, Schurr E (2003) Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 33:412-415
35. Pearson RD, Sousa AQ (1996) Clinical spectrum of leishmaniasis. Clin Infect Dis 22:1-13
36. Petzl-Erler ML, Belich MP, Queiroz-Telles F (1991) Association of mucosal leishmaniasis with HLA. Hum Immunol 32: 254-260
37. Pratlong F, Dereure J, Bucheton B, El-Saf S, Dessein A, Lanotte G, Dedet JP (2001) Sudan: the possible original focus of visceral leishmaniasis. Parasitology 122:599-605
38. Risch N (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46:229-241
39. Roberts M, Mock BA, Blackwell JM (1993) Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur J Immunogenet 20:349-362
40. Seaman J, Mercer AJ, Sondorp E (1996) The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25: 862-871
41. Siddiqui MR, Meisner S, Tosh K, Balakrishnan K, Ghei S, Fisher SE, Golding M, Shanker Narayan NP, Sitaraman T, Sengupta U, Pitchappan R, Hill AV (2001) A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 27:439-441
42. Southgate BA, Manson-Bahr PE (1967) Studies in the epidemiology of East African leishmaniasis. IV. The significance of the positive leishmanin test. J Trop Med Hyg 70:29-33
43. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P (1995) The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 182:655-666
44. Zijlstra EE, el-Hassan AM, Ismael A, Ghalib HW (1994) Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51: 826-836